1552 studies found for:    glioma
Show Display Options
Rank Status Study
1 Recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Conditions: Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma
Interventions: Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
2 Unknown  Gene Expression, Immunological Status and Metabolome in Glioma Patients
Condition: Glioma
Interventions: Procedure: Glioma resection;   Other: Blood sampling
3 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
4 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma.;   Newly Diagnosed Pediatric High Grade Glioma.;   Recurrent Pediatric High Grade Glioma.;   Recurrent Pediatric Low Grade Glioma.
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
5 Active, not recruiting A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Conditions: Newly Diagnosed High-Grade Gliomas;   Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
6 Completed An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Conditions: Brain Metastases;   Lung Cancer;   Breast Cancer;   Melanoma;   Malignant Glioma
Interventions: Drug: 2B3-101;   Drug: Trastuzumab;   Drug: 2B3-101 60 mg/m2 every 4 weeks;   Drug: 2B3-101 50 mg/m2 every 3 weeks
7 Not yet recruiting Case-cohort Study of Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma
Condition: Glioma
Interventions: Drug: Midazolam;   Drug: propofol;   Drug: Dexmedetomidine
8 Enrolling by invitation Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma
Condition: High Grade Glioma
Intervention:
9 Completed Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
Conditions: Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Drug: LS11 (talaporfin sodium);   Device: Light source (interstitial light emitting diodes);   Procedure: Intraoperative placement of device in glioma
10 Completed A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
Conditions: Mixed Gliomas;   Malignant Gliomas;   Glioblastoma Multiforme
Interventions: Drug: XL765 (SAR245409);   Drug: Temozolomide
11 Not yet recruiting Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
Condition: Recurrent High-grade Glioma
Interventions: Drug: Ultra-low dose Bevacizumab;   Drug: Temozolomide
12 Recruiting 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
Conditions: Glioma;   Breast Cancer
Intervention: Radiation: 68Ga-NOTA-NFB
13 Not yet recruiting A Phase II Study of NovoTTF-100A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Condition: Glioma
Interventions: Device: NovoTTF-100A;   Drug: Temozolomide
14 Recruiting Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Condition: Glioma
Interventions: Procedure: MRS Imaging;   Procedure: PET Scanning;   Procedure: Diffusion Tensor Imaging
15 Recruiting Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Conditions: Cholangiocarcinoma;   Chondrosarcoma;   Glioma;   Other Advanced Solid Tumors
Intervention: Drug: AG-120
16 Completed A Phase II Study to Treat Advanced Malignant Glioma
Condition: Advanced Malignant Glioma
Interventions: Drug: AMG 102 at 20 mg/kg;   Drug: AMG 102 at 10 mg/kg
17 Recruiting Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma
Condition: Glioma
Intervention: Procedure: CM-BC2 Irinotecan drug-eluting bead
18 Completed AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Malignant Glioma;   Brainstem Glioma
Intervention: Drug: AZD8055
19 Completed Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Glioma
Intervention: Drug: Temodar and O6-Benzylguanine (BG)
20 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years